Kidney Tumors Program

Meet the team

Our physicians are focused on family-centered care: From your first visit, you’ll work with a team of professionals who are committed to supporting all of your family’s physical and psychosocial needs.

• Elizabeth A. Mullen, MD, Director of the Kidney Tumors Program
  Mullen, Director of the Kidney Tumor Program at Dana-Farber/Children’s Hospital Cancer Care, is actively involved in the treatment of pediatric kidney tumors, as well as educating future generations of pediatric oncologists.
  
  Mullen has contributed chapters on the treatment of pediatric renal tumors to many of the academic textbooks, including Nathan and Oski’s Hematology of Infancy and Childhood, Pediatric Nephrology, and theTextbook of Pediatric Hospital Medicine.She is alsoVice Chair of two of the Children’s Oncology Group (COG) clinical trials on the treatment of kidney tumors.
• Thomas Hamilton, MD
  Hamiltonis a pediatric general surgeon with expertise in neonatal surgery, surgical oncology and thoracic surgery. He also serves as Chief of Pediatric Surgery at Boston University School of Medicine. He holds teaching appointments at both Boston University School of Medicine and Harvard Medical School.
• Karen J. Marcus, MD
  Marcus joined DF/CHCC in 1989 and specializes in pediatric oncology and radiation oncology. She treats children with a wide variety of cancers including brain tumors, sarcomas, neuroblastoma, leukemias, kidney tumors and Hodgkin lymphoma. She’s an associate professor at Harvard Medical School and co-chair of Pediatric Oncology Institutional Review Board.
• Nancy Rodig, MD
  Rodig is a pediatric nephrologist specializing in kidney transplant. In addition, she is an instructor in pediatrics at Harvard Medical School.
• Robert C. Shamberger, MD
  Shamberger is Children’s Chief of Surgery and has expertise in surgical oncology. He is a professor of Surgery at Harvard Medical School. His research focuses on the treatment of neuroblastoma, Ewing’s sarcoma, Wilms’ tumor and inflammatory bowel disease.
• Stephan D. Voss, MD, PhD
  Voss is a staff radiologist and researcher at Children’s. His research focuses on developing new methods for imaging malignant disease, specifically pediatric neuroblastoma. In addition, he is an assistant professor of radiology at Harvard Medical School.
• Christopher Weldon, MD, PhD
  Weldon is a pediatric general surgeon with expertise in pediatric oncology and surgical critical care. His research focuses on chemotherapy resistance in solid tumors. He is also an instructor at Harvard Medical School.